Carol R. Lizak Jaguar Health, Inc. (JAGX) insider trading activity

JAGX Quotes by TradingView

Carol R. Lizak is Chief Financial Officer of Jaguar Health, Inc.. Currently has a direct ownership of 1,042 shares of JAGX, which is worth approximately $1,156. The most recent transaction as insider was on May 17, 2024, when has been sold 431 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.04K
0% 3M change
99.27% 12M change
Total Value Held $1,156

Carol R. Lizak Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
BUY
Exercise of conversion of derivative security
-
431 Added 29.26%
1,042 Common Stock
Apr 05 2024
BUY
Exercise of conversion of derivative security
-
60 Added 8.94%
611 Common Stock
Aug 14 2023
BUY
Grant, award, or other acquisition
-
142,088 Added 49.88%
142,745 Common Stock
May 17 2023
BUY
Exercise of conversion of derivative security
-
431 Added 39.61%
657 Common Stock
Apr 05 2023
BUY
Exercise of conversion of derivative security
-
60 Added 20.98%
226 Common Stock
Apr 05 2022
BUY
Exercise of conversion of derivative security
-
4,513 Added 26.56%
12,481 Common Stock
CRL

Carol R. Lizak

Chief Financial Officer
San Francisco, CA

Track Institutional and Insider Activities on JAGX

Follow Jaguar Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAGX shares.

Notify only if

Insider Trading

Get notified when an Jaguar Health, Inc. insider buys or sells JAGX shares.

Notify only if

News

Receive news related to Jaguar Health, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JAGX